Ultragenyx Pharmaceutical(RARE) - 2025 FY - Earnings Call Transcript

Ultragenyx Pharmaceutical (NasdaqGS:RARE) FY 2025 Conference December 02, 2025 03:15 PM ET Company ParticipantsEric Crombez - Chief Medical OfficerConference Call ParticipantsYigal Nochomovitz - Biotech AnalystYigal NochomovitzWe can get started. Welcome, everyone. I'm Yigal Nochomovitz, one of the biotech analysts at Citi, and welcome to our Global Healthcare Conference in Miami. So our next session is with Ultragenyx. We have the Chief Medical Officer, Eric Crombez. Eric, welcome. Thank you for making the ...